1. by James O. Armitage, and Dan L. Longo
Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
by James O. Armitage, and Dan L. Longo
Blood
Volume 127(23):
June 9, 2016
©2016 by American Society of Hematology

2. Overall survival of patients with grade 1 or 2 FL treated by physicians in the Nebraska Lymphoma Study Group between 1982 and 2014.
Overall survival of patients with grade 1 or 2 FL treated by physicians in the Nebraska Lymphoma Study Group between 1982 and (A) Patients treated before or after (B) Patients who did, or did not, ever receive rituximab.
James O. Armitage, and Dan L. Longo Blood 2016;127:
©2016 by American Society of Hematology